GMZPX
Price
$36.87
Change
-$0.44 (-1.18%)
Updated
Aug 29 closing price
Net Assets
1.55B
RGEBX
Price
$81.56
Change
-$0.76 (-0.92%)
Updated
Aug 29 closing price
Net Assets
327.53B
Interact to see
Advertisement

GMZPX vs RGEBX

Header iconGMZPX vs RGEBX Comparison
Open Charts GMZPX vs RGEBXBanner chart's image
Goldman Sachs Large Cap Gr Insghts P
Price$36.87
Change-$0.44 (-1.18%)
VolumeN/A
Net Assets1.55B
American Funds Growth Fund of Amer R2E
Price$81.56
Change-$0.76 (-0.92%)
VolumeN/A
Net Assets327.53B
GMZPX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMZPX vs. RGEBX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMZPX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 328B vs. GMZPX (1.55B). GMZPX pays higher dividends than RGEBX: GMZPX (0.05) vs RGEBX (0.00). GMZPX was incepted earlier than RGEBX: GMZPX (7 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than GMZPX (0.58). GMZPX is a more actively managed with annual turnover of: 215.00 vs. RGEBX (25.00). GMZPX has a lower initial minimum investment than RGEBX: GMZPX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 13.67 vs. GMZPX (9.90). RGEBX return over 5 years is better than : 33.24 vs. GMZPX (-10.36).
GMZPXRGEBXGMZPX / RGEBX
Total Expense Ratio0.551.0950%
Annual Report Gross Expense Ratio0.581.0953%
Fund Existence7 years11 years-
Gain YTD9.96214.16670%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B328B0%
Annual Yield % from dividends0.050.00-
Returns for 1 year9.9013.6772%
Returns for 3 years33.1452.5863%
Returns for 5 years-10.3633.24-31%
Returns for 10 yearsN/A94.86-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMND1.050.03
+3.43%
Clearmind Medicine
OVID1.280.03
+2.40%
Ovid Therapeutics
CNA49.550.44
+0.90%
CNA Financial Corp
FRPH25.70-0.13
-0.50%
FRP Holdings
EPAC42.34-0.54
-1.26%
Enerpac Tool Group Corp